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Reported Pertussis Cases
2015:    20,762 2016:    15,737
Reported Pertussis Cases and Percent 
Hospitalization by Age Group 





< 6 mos 1253 (8) 85.5 44.5
6-11 mos 540 (3.4) 27.1 11.9
1-6 yrs 2879 (18.3) 11.9 2.3
7-10 yrs 2161 (13.7) 12.7 1.2
11-19 yrs 5237 (33.3) 13.9 1
20+ yrs 3478 (22.1) 1.4 7.8
Unknown Age 189 (1.2) N/A N/A
Total 15737 (100.0) 4.7* 6.5
*Total age incidence per 100,000 calculated from 15,548 cases with age reported.
**Age-specific proportion of cases that were hospitalized, calculated from those with 





< 1 yr 6
Cases, aged   
> 1 yr 1
Total 7
*Deaths reported through NNDSS 
to CDC. Confirmation of non-infant 
deaths is ongoing and may result in 
changes to the final pertussis-related 
death count for 2016.
†4 of the 7 deaths were female.
Reported DTaP Vaccine Status of Children with Pertussis, 
Ages 6 months through 6 years




DTaP Series  
(3+ doses)
Total
No. (%) No. (%) No. (%)        No. (%) No.
6-11 mo 209 (38) 42 (8) 85 (16) 204 (38) 540
1-4 yrs 785 (36) 173 (8) 100 (5) 1093 (51) 2151
5-6 yrs 226 (31) 47 (6) 19 (3) 436 (60) 728
Total* 1220 (36) 262 (9)   204 (6)     1733 (49) 3419
*Percent calculated from total cases aged 6 months to 6 years, n=3,419.
Footnote: This table reflects reported vaccination history of pertussis cases aged 6 months through 6 years. CDC recommends 
all children receive 3 doses of DTaP by age 6 months. DTaP coverage in the United States is high; over 95% of children aged 19-35 
months have received 3 doses of DTaP. This table illustrates a similar trend among pertussis cases reported in 2016—the majority 
received at least 3 doses of DTaP. Because protection from DTaP wanes over time, even children who are up to date with DTaP may 
contract pertussis. Unvaccinated children are more likely to contract pertussis and have more severe disease than those who are 
fully vaccinated. Note: surveillance data have limitations and are often incomplete; more than a third of pertussis cases in this table 
have unknown pertussis vaccination history.
Source: NCHS Bridged Race Intercensal 
Population Estimate for 2015; 2016 estimate  
was not available at the time of publication
